Scientists use DNA mapping and AI to hunt for better myeloma treatments
NCT ID NCT06338150
Summary
This 2-year study aims to improve personalized treatment for multiple myeloma by analyzing the genetic makeup of patients' tumors. Researchers will collect tumor and blood samples from 100 participants with relapsed multiple myeloma and use advanced sequencing technology to identify genetic changes. The goal is to understand how these genetic patterns might guide better treatment choices in the future, using computer analysis to interpret the complex data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Mount Sinai Health System
RECRUITINGNew York, New York, 10029, United States
Contact
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.